Erik Elenko | BiotechTV

top of page

PureTech, which is built on a hub and spoke model of creating biotechs, recently received positive end of phase 1 feedback from FDA on its galectin-9 targeting cancer medicine from Gallop Oncology

PureTech CEO Robert Lyne and Co-Founder Eric Elenko share an update on PureTech and discuss the galectin-9 target and what is next for this program.

Company News

1 day ago

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

Learn more

bottom of page

PureTech, which is built on a hub and spoke model of creating biotechs, recently received positive end of phase 1 feedback from FDA on its galectin-9 targeting cancer medicine from Gallop Oncology

Follow BiotechTV

Sponsors

Sponsor Spotlight